Last10K.com

Lantheus Holdings, Inc. (LNTH) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2018

Lantheus Holdings, Inc.

CIK: 1521036 Ticker: LNTH


Exhibit 99.1
lantheus.jpg
331 Treble Cove Road
North Billerica, MA 01862
800.362.2668
www.lantheus.com
Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
Worldwide revenues of $86.3 million and $343.4 million for fourth quarter and full year 2018, respectively; representing an increase of 6.2% and 3.6% over the prior year period, respectively
Net income of $13.3 million and $40.5 million for the fourth quarter and full year 2018, representing a decrease of $83.8 million and $82.9 million over the prior period, respectively, driven by adjustments in tax reporting resulting in a net tax benefit of $85.9 million that was realized in 2017
EBITDA of $20.0 million and $77.9 million for fourth quarter and full year 2018, representing an increase of 55.6% and 13.0% over the prior year period, respectively; adjusted EBITDA of $25.2 million and $98.1 million for fourth quarter and full year, representing an increase of 21.0% and 4.3% over the prior year period, respectively
The Company provides first quarter and full year 2019 revenue and adjusted fully diluted earnings per share guidance
NORTH BILLERICA, Mass., February 19, 2019 - Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today reported financial results for its fourth quarter and full year ended December 31, 2018.
The Company’s worldwide revenues for the fourth quarter of 2018 totaled $86.3 million, compared with $81.2 million for the fourth quarter of 2017, representing an increase of 6.2% over the prior year period. Full year 2018 worldwide revenues were $343.4 million, compared with $331.4 million in 2017, representing an increase of 3.6% over the prior year.
The Company’s fourth quarter 2018 net income was $13.3 million, or 15.4% of revenues, as compared to $97.1 million, or 119.6% of revenues in 2017, representing a decrease of 86.3%, or $83.8 million, over the prior year period. Full year 2018 net income was $40.5 million, or 11.8% of revenues, as compared to $123.4 million, or 37.2% of revenues in 2017, representing a decrease of $82.9 million, or 67.2%, over the prior year. The fourth quarter and full year 2018 decrease is driven by adjustments in tax reporting resulting in a net tax benefit of $85.9 million that was realized in 2017.
The Company’s fourth quarter 2018 EBITDA was $20.0 million, or 23.1% of revenues, as compared to $12.8 million, or 15.8% of revenues in 2017, representing an increase of 55.6% over the prior year period. Full year 2018 EBITDA was $77.9 million, or 22.7% of revenues, as compared to $68.9 million, or 20.8% of revenues in 2017, representing an increase of 13.0% over the prior year. Adjusted EBITDA for the fourth quarter 2018 was $25.2 million, or 29.2% of revenues, compared to $20.8 million, or 25.7% of revenues in 2017, representing an increase of 21.0% over the prior year period. Full year 2018 adjusted EBITDA was $98.1 million, or 28.6% of revenues, compared to $94.1 million, or 28.4% of revenues in 2017, representing an increase of 4.3% over the prior year. See “Non-GAAP Measures” below for a reconciliation of EBITDA and adjusted EBITDA to net income.
“The fourth quarter marked a great finish to a strong year for Lantheus,” said Mary Anne Heino, President and CEO of Lantheus. “We delivered another solid quarter with 6.2% revenue growth, supported by continued mid-teens worldwide sales growth of DEFINITY. Our 2018 performance is a testament to the strength of the Lantheus team and the opportunities afforded us as a partner of choice in the markets we serve. We enter 2019 confident that Lantheus is well positioned to drive sustainable growth in a dynamic healthcare environment.”
Outlook
The Company guidance for the first quarter and full year 2019 is as follows:

Page 1 of 10

The following information was filed by Lantheus Holdings, Inc. (LNTH) on Tuesday, February 19, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Lantheus Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Lantheus Holdings, Inc..

Continue

Assess how Lantheus Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Lantheus Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Rating

Learn More
Bullish Bearish Neutral
Filter by Sentiment:
All
Positive
Negative
Filter by Category:
All
Revenue
Financial
Legal
Other
Filter by Subcategory:
All
Product
Expense
Income
Earnings
Cash Flow
Debt
Shares
Other
Inside Lantheus Holdings, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Cash Flows (Parenthetical)
Consolidated Statements Of Changes In Stockholders' Deficit (Parenthetical)
Consolidated Statements Of Changes In Stockholders' Equity (Deficit)
Consolidated Statements Of Comprehensive Income (Loss)
Consolidated Statements Of Operations
401(K) Plan
401(K) Plan - Additional Information (Detail)
Accrued Expenses And Other Liabilities
Accrued Expenses And Other Liabilities (Detail)
Accrued Expenses And Other Liabilities (Tables)
Asset Retirement Obligations
Asset Retirement Obligations (Tables)
Asset Retirement Obligations - Additional Information (Detail)
Asset Retirement Obligations - Schedule Of Reconciliation Of Company's Asset Retirement Obligations (Detail)
Commitments (Tables)
Commitments - Additional Information (Detail)
Commitments - Schedule Of Minimum Lease And Purchase Commitments Under Noncancelable Arrangements (Detail)
Commitments And Contingencies
Description Of Business
Description Of Business (Details)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (Detail)
Fair Value Of Financial Instruments (Tables)
Financing Arrangements
Financing Arrangements (Tables)
Financing Arrangements - Additional Information (Detail)
Financing Arrangements - Revolving Facility (Details)
Financing Arrangements - Schedule Of Minimum Payments Maturities Of Principal Obligations Under Term Facility (Detail)
Financing Arrangements - Schedule Of Term Facility Financial Covenants (Detail)
Financing Arrangements - Term Facility (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Detail)
Income Taxes - Components Of Deferred Income Tax Assets (Liabilities) (Detail)
Income Taxes - Differences In Statutory Rate And Effective Rate (Detail)
Income Taxes - Reconciliation Of Uncertain Tax Positions (Detail)
Income Taxes - Schedule Of (Benefit) Provision For Income Taxes (Detail)
Income Taxes - Schedule Of Components Of Income (Loss) Before Income Taxes (Detail)
Income Taxes - Valuation Allowance (Details)
Intangibles, Net
Intangibles, Net (Tables)
Intangibles, Net - Additional Information (Detail)
Intangibles, Net - Schedule Of Expected Future Amortization Expense Related To Intangible Assets (Detail)
Intangibles, Net - Schedule Of Intangibles, Net (Detail)
Inventory
Inventory (Tables)
Inventory - Additional Information (Detail)
Inventory - Schedule Of Inventory (Detail)
Net Income (Loss) Per Common Share
Net Income (Loss) Per Common Share (Tables)
Net Income (Loss) Per Common Share - Summary Of Net Income (Loss) Per Common Share (Detail)
Property, Plant &Amp; And Equipment, Net - Schedule Of Property, Plant &Amp; Equipment (Detail)
Property, Plant &Amp; Equipment, Net
Property, Plant &Amp; Equipment, Net (Tables)
Property, Plant &Amp; Equipment, Net - Additional Information (Detail)
Quarterly Consolidated Financial Data (Detail)
Quarterly Consolidated Financial Data (Unaudited)
Quarterly Consolidated Financial Data (Unaudited) (Tables)
Revenue From Contracts With Customers
Revenue From Contracts With Customers (Tables)
Revenue From Contracts With Customers - Contract Costs (Details)
Revenue From Contracts With Customers - Disaggregation Of Revenue (Details)
Revenue From Contracts With Customers - Rebates And Allowances (Details)
Sales Of Certain International Segment Assets
Sales Of Certain International Segment Assets (Detail)
Segment Information
Segment Information (Tables)
Segment Information - Additional Information (Detail)
Segment Information - Schedule Of Selected Information For Each Business Segment (Detail)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation - Employee Stock Purchase Plan (Details)
Stock-Based Compensation - Equity Incentive Plans (Details)
Stock-Based Compensation - Modifications (Details)
Stock-Based Compensation - Schedule Of Stock-Based Compensation Expense Recognized (Detail)
Stock-Based Compensation - Stock Options (Detail)
Stock-Based Compensation - Summary Of Performance Restricted Stock Awards Activity (Details)
Stock-Based Compensation - Summary Of Restricted Stock Awards Activity (Detail)
Stock-Based Compensation - Summary Of Tsr Award Activity (Details)
Stock-Based Compensation - Total Stockholder Return Restricted Awards (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Accounts Receivable (Details)
Summary Of Significant Accounting Policies - Advertising And Promotion Costs (Details)
Summary Of Significant Accounting Policies - Concentration Risk (Detail)
Summary Of Significant Accounting Policies - Estimated Useful Lives (Detail)
Summary Of Significant Accounting Policies - Goodwill (Details)
Summary Of Significant Accounting Policies - Inventory (Details)
Summary Of Significant Accounting Policies - Other Income (Detail)
Summary Of Significant Accounting Policies - Self-Insurance Reserves (Details)
Valuation And Qualifying Accounts
Valuation And Qualifying Accounts (Detail)
Valuation And Qualifying Accounts (Tables)
Ticker: LNTH
CIK: 1521036
Form Type: 10-K Annual Report
Accession Number: 0001628280-19-001574
Submitted to the SEC: Wed Feb 20 2019 4:07:53 AM EST
Accepted by the SEC: Wed Feb 20 2019
Period: Monday, December 31, 2018
Industry: In Vitro And In Vivo Diagnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/lnth/0001628280-19-001574.htm